Evidence map›Paper›PMID 15208459›Full record

ReviewClinical reviews in allergy & immunology2004

Allergy prevention. Interventions during pregnancy and early infancy.

Bengt Björkstén

Abstract readReview
PubMed Publisher
In one paragraph

Review in Clinical reviews in allergy & immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Bengt BjörksténCenter for Allergy Research and Department of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. bengt.bjorksten@cfa.ki.se
Karolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increase in allergic disease in western, industrialized countries has been phenomenal. Although the reasons for this increase are unknown, it is clear that the primary management of allergies is prevention. There is now significant epidemiologic data suggesting that a program designed and focused on prevention will have a significant impact on the development of allergies. These include not only environmental, but also dietary restrictions. There remain, however, several major problems. Firstly, it is not clear which subjects will respond best to a program focusing on either pre-or postnatal prevention. Secondly, the immunological mechanisms involved remain unclear. For example, it would be highly desirable to have a readout that monitors the improvement in allergen avoidance, other than clinical response. This review will focus on the immunological background of allergy prevention, including epidemiologic observations and thoughts for future potential allergy prevention.

Indexed as

FemaleHumansHypersensitivityImmune SystemImmunity, CellularInfant, NewbornInfant WelfareMaternal WelfarePregnancyPregnancy ComplicationsPrimary Prevention

Identifiers

PMID15208459
OpenAlexW2326141860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.